[EPO] T CELLS WITH ENHANCED GLUCOSE UPTAKE ABILITY ON-DEMAND, CELL POPULATION, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME

Part of

Engineered T Cell Immunotherapy Advances